Hartman Institute for Therapeutic Organ Regeneration

Tmem88a mediates GATA-dependent specification of cardiomyocyte progenitors by restricting WNT signaling.

TitleTmem88a mediates GATA-dependent specification of cardiomyocyte progenitors by restricting WNT signaling.
Publication TypeJournal Article
Year of Publication2013
AuthorsNovikov N, Evans T
JournalDevelopment
Volume140
Issue18
Pagination3787-98
Date Published2013 Sep
ISSN1477-9129
KeywordsAnimals, Apoptosis, Biomarkers, Body Patterning, Cardiomyopathies, Cell Lineage, Cell Proliferation, Down-Regulation, Embryo, Nonmammalian, GATA Transcription Factors, GATA5 Transcription Factor, Gene Expression Regulation, Developmental, Genetic Association Studies, Membrane Proteins, Mesoderm, Morpholinos, Mutation, Myocardium, Myocytes, Cardiac, Organogenesis, Phenotype, RNA Transport, RNA, Messenger, Stem Cells, Wnt Signaling Pathway, Zebrafish, Zebrafish Proteins
Abstract

<p>Biphasic control of WNT signaling is essential during cardiogenesis, but how the pathway switches from promoting cardiac mesoderm to restricting cardiomyocyte progenitor fate is unknown. We identified genes expressed in lateral mesoderm that are dysregulated in zebrafish when both gata5 and gata6 are depleted, causing a block to cardiomyocyte specification. This screen identified tmem88a, which is expressed in the early cardiac progenitor field and was previously implicated in WNT modulation by overexpression studies. Depletion of tmem88a results in a profound cardiomyopathy, secondary to impaired cardiomyocyte specification. In tmem88a morphants, activation of the WNT pathway exacerbates the cardiomyocyte deficiency, whereas WNT inhibition rescues progenitor cells and cardiogenesis. We conclude that specification of cardiac fate downstream of gata5/6 involves activation of the tmem88a gene to constrain WNT signaling and expand the number of cardiac progenitors. Tmem88a is a novel component of the regulatory mechanism controlling the second phase of biphasic WNT activity essential for embryonic cardiogenesis.</p>

DOI10.1242/dev.093567
Alternate JournalDevelopment
PubMed ID23903195
PubMed Central IDPMC3754477
Grant ListR01 HL111400 / HL / NHLBI NIH HHS / United States
T32 GM007739 / GM / NIGMS NIH HHS / United States
HL111400 / HL / NHLBI NIH HHS / United States
GM07739 / GM / NIGMS NIH HHS / United States

Weill Cornell Medicine
Hartman Institute for Therapeutic Organ Regeneration
1300 York Ave, Box 136 New York, NY 10065